Genome Annotation Services Market Report 2026

The genome annotation services market size has grown rapidly in recent years. It will grow from $1.44 billion in 2025 to $1.63 billion in 2026 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to expansion of genome sequencing projects, increased availability of NGS data, growth in academic genomics research, rising use of bioinformatics in drug discovery, development of public genomic databases.

The genome annotation services market size is expected to see rapid growth in the next few years. It will grow to $2.75 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for personalized medicine research, rising adoption of AI-driven bioinformatics platforms, expansion of precision agriculture genomics, growing investment in genomics startups, increasing integration of clinical genomics workflows. Major trends in the forecast period include increasing use of automated gene annotation pipelines, rising adoption of AI-based functional annotation, growing demand for comparative genome analysis, expansion of multi-omics annotation services, enhanced focus on high-quality manual curation.

The increasing demand for personalized medicine is anticipated to drive the growth of the genome annotation services market in the coming years. Personalized medicine refers to a medical approach that customizes healthcare decisions, treatments, and interventions based on the unique characteristics of each patient, including their genetic profile, lifestyle, and environment. The increasing demand for personalized medicine is mainly driven by the growing prevalence of chronic and complex diseases, as tailored treatments can more effectively address individual patient needs and enhance health outcomes. Genome annotation services facilitate personalized medicine by converting raw genomic data into clinically actionable insights, enabling treatments and therapies to be precisely tailored to an individual’s genetic makeup, disease susceptibility, and drug response. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing demand for personalized medicine is fueling the growth of the genome annotation services market.

Companies operating in the genome annotation services market are focusing on developing new in-house prokaryotic genome annotation pipelines to deliver more consistent, accurate, and scalable annotations across large genome datasets. New in-house prokaryotic genome annotation pipelines use standardized, automated workflows combining advanced gene prediction and functional annotation tools to produce consistent, high-quality annotations across large numbers of microbial genomes. For example, in July 2023, the European Molecular Biology Laboratory's European Bioinformatics Institute, a UK-based molecular biology laboratory, launched a comprehensive new annotation for all genomes hosted in Ensembl Bacteria. This update introduced a standardized, in-house prokaryotic annotation pipeline, replacing the earlier reliance on heterogeneous submitter-provided annotations. The initiative delivered consistent gene prediction, functional annotation, and systematic gene identifiers across tens of thousands of bacterial and archaeal genomes. Overall, the release significantly improved data comparability, annotation quality, and usability for large-scale comparative genomics and microbiome research.

In September 2025, SeqOne, a France-based AI-driven genomic analysis provider, acquired Congenica for an undisclosed sum. Through this acquisition, SeqOne seeks to enhance its global presence and technological capabilities by integrating its AI-powered genomic analysis platform with Congenica’s clinical decision support and interpretation services to accelerate personalized medicine and broaden its market reach. Congenica is a UK-based healthcare technology company specializing in comprehensive genome annotation, interpretation, and analysis services.

Major companies operating in the genome annotation services market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Charles River Laboratories International Inc., QIAGEN N.V., Macrogen Inc., Novogene Co. Ltd., Pacific Biosciences of California Inc., SOPHiA GENETICS, DNAnexus Inc., Zymo Research Corporation, GOENOMICS GmbH, CD Genomics, Eagle Genomics Ltd., DNASTAR Inc., Lexogen GmbH, Beijing Genomics Institute Group, and BioBam Bioinformatics S.L.

Tariffs are influencing the genome annotation services market by increasing costs associated with imported high-performance computing hardware, data storage systems, specialized servers, and bioinformatics infrastructure components. Research institutions and biotechnology companies in North America and Europe are most affected due to dependence on advanced imported computing systems, while Asia-Pacific faces cost pressure on infrastructure expansion. These tariffs are raising operational expenses for large-scale genomic projects and slowing infrastructure upgrades. However, they are also encouraging cloud-based service adoption, regional data center investments, and localized development of bioinformatics platforms and analytical capabilities.

The genome annotation services market research report is one of a series of new reports that provides genome annotation services market statistics, including genome annotation services industry global market size, regional shares, competitors with a genome annotation services market share, detailed genome annotation services market segments, market trends and opportunities, and any further data you may need to thrive in the genome annotation services industry. This genome annotation services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genome annotation services are professional bioinformatics and computational services that examine raw genomic sequence data to identify, classify, and interpret genes, coding regions, regulatory elements, and other functional components within a genome. These services facilitate biological research, drug discovery, and clinical studies by converting genomic data into organized, biologically meaningful information.

The key service types of genome annotation services include structural annotation, functional annotation, comparative annotation, and other related services. Structural annotation involves identifying genomic elements such as genes, coding regions, and regulatory sequences within DNA sequences. These services leverage technologies like next-generation sequencing, Sanger sequencing, and other advanced methods. Their applications include drug discovery, personalized medicine, agriculture, biotechnology, and more, with end users including pharmaceutical and biotechnology companies, academic and research institutions, clinical laboratories, and other relevant organizations.

The genome annotation services market includes revenues earned by entities by providing services such as gene prediction, functional annotation, structural annotation, comparative genome analysis, pathway annotation, variant annotation, manual curation, annotation quality assessment, database integration, and custom bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.